FLT1 anticorps (C-Term)
Aperçu rapide pour FLT1 anticorps (C-Term) (ABIN2385081)
Antigène
Voir toutes FLT1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Réactivité croisée
- Humain
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu
-
Attributs du produit
- VEGF Receptor 1 (Flt1, VEGFR1, Vascular Endothelial Growth Factor Receptor 1)
-
Purification
- Purified by immunoaffinity chromatography.
-
Immunogène
- Synthetic peptide corresponding to the C-terminal domain of human Vascular Endothelial Growth Factor Receptor 1 (KLH).
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- 4°C (-20°C Glycerol)
-
-
- FLT1 (Fms-Related tyrosine Kinase 1 (VEGFR1) (FLT1))
-
UniProt
- P17948
-
Pathways
- Signalisation RTK, Signaling Events mediated by VEGFR1 and VEGFR2, VEGFR1 Specific Signals
Antigène
-